Intersect ENT is a US-based commercial stage drug-device company that specializes in providing therapeutic solutions for patients with ear, nose, and throat conditions. The company is known for its PROPEL and PROPEL mini drug releasing implants that are used to treat chronic sinusitis in patients undergoing sinus surgery. Intersect ENT is committed to improving the quality of life of patients by developing innovative technologies that address unmet medical needs in the ENT market.
Intersect ENT Inc's ticker is XENT
The company's shares trade on the NASDAQ stock exchange
They are based in Menlo Park, California
There are 201-500 employees working at Intersect ENT Inc
It is http://www.intersectent.com/
Intersect ENT Inc is in the Healthcare sector
Intersect ENT Inc is in the Medical Appliances & Equipment industry
The following five companies are Intersect ENT Inc's industry peers: